UC AKT.ANL. 09/24 OMV/ DE000HD13QK2 /
12/06/2024 21:46:27 | Chg.-0.010 | Bid21:59:30 | Ask21:59:30 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
101.840EUR | -0.01% | 101.470 Bid Size: 20,000 |
102.040 Ask Size: 20,000 |
OMV AG | 30.4064 EUR | 27/09/2024 | Call |
GlobeNewswire
26/03
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
13/10/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
euro adhoc
28/07/2021
EANS-Tip Announcement: OMV Aktiengesellschaft / Half-year financial report according to art. 125 par...
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center